Search Within

Chau Dang

Formats
  1. Journal Article (132)
  2. Meeting Abstract (122)
  3. Guidelines (8)
  4. Book Section (4)
  5. Review (3)
  6. Book Whole (1)
  7. Editorial (1)
  8. Miscellaneous (1)
  9. Research Letter (1)
Groups
  1. Breast Medicine Service (273)
  2. Department of Medicine (273)
  3. Solid Tumor Oncology Division (273)
  4. Survivorship Research (273)
  5. Population Sciences Research Program (119)
  6. Epidemiology and Biostatistics (93)

More Groups

People
  1. Clifford Hudis (111)
  2. Larry Norton (76)
  3. Richard Steingart (49)
  4. Anthony Yu (46)
  5. Shanu Modi (42)
  6. Sujata Patil (41)

More People

Years
  1. 2025 (4)
  2. 2024 (12)
  3. 2023 (15)
  4. 2022 (18)
  5. 2021 (12)
  6. 2020 (20)

More Years

Publications
  1. Journal of Clinical Oncology (68)
  2. Cancer Research (42)
  3. Breast Cancer Research and Treatment (23)
  4. Annals of Oncology (10)
  5. Clinical Breast Cancer (7)
  6. Clinical Cancer Research (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (70)
  2. American Association for Cancer Research (50)
  3. Springer (33)
  4. Oxford University Press (22)
  5. Elsevier Inc. (16)
  6. American Medical Association (11)

More Publishers

Results (273)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Trastuzumab interruption for treatment-induced cardiotoxicity in HER2 positive early breast cancer
    Meeting Abstract

    Yu, A. F.; Yadav, N. U.; Lung, B. Y.; Eaton, A. A.; Thaler, H. T.; Hudis, C. A.; Dang, C. T.; Steingart, R. M.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • A two-cohort, phase II, cardiac safety study of pertuzumab, trastuzumab, and neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive, locally advanced, inflammatory, or early breast cancer
    Meeting Abstract

    Swain, S. M.; Ewer, M. S.; Douthwaite, H.; Szado, T.; Waldron-Lynch, M.; Dang, C.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Mutational analysis of CALGB 40601 (Alliance), a neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-positive breast cancer
    Meeting Abstract

    Hoadley, K. A.; Barry, W. T.; Pitcher, B. N.; Parker, J. S.; Wilkerson, M. D.; Irvin, W.; Henry, N. L.; Tolaney, S. M.; Dang, C.; Krop, I. E.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Chemotherapy-related amenorrhea after adjuvant paclitaxel–trastuzumab (APT trial)
    Journal Article

    Ruddy, K. J.; Guo, H.; Barry, W.; Dang, C. T.; Yardley, D. A.; Moy, B.; Marcom, P. K.; Albain, K. S.; Rugo, H. S.; Ellis, M. J.; more...
    Breast Cancer Research and Treatment (2015)

    Fulltext@MSK | Save
  • Feasibility and cardiac safety of trastuzumab emtansine after anthracycline-based chemotherapy as (neo)adjuvant therapy for human epidermal growth factor receptor 2-positive early-stage breast cancer
    Journal Article

    Krop, I. E.; Suter, T. M.; Dang, C. T.; Dirix, L.; Romieu, G.; Zamagni, C.; Citron, M. L.; Campone, M.; Xu, N.; Smitt, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Trastuzumab interruption and treatment-induced cardiotoxicity in early HER2-positive breast cancer
    Journal Article

    Yu, A. F.; Yadav, N. U.; Lung, B. Y.; Eaton, A. A.; Thaler, H. T.; Hudis, C. A.; Dang, C. T.; Steingart, R. M.
    Breast Cancer Research and Treatment (2015)

    Fulltext@MSK | Save
  • Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer
    Journal Article

    Tolaney, S. M.; Barry, W. T.; Dang, C. T.; Yardley, D. A.; Moy, B.; Marcom, P. K.; Albain, K. S.; Rugo, H. S.; Ellis, M.; Shapira, I.; more...
    New England Journal of Medicine (2015)

    Fulltext@MSK | Save
  • Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
    Journal Article

    Dang, C.; Iyengar, N.; Datko, F.; D'Andrea, G.; Theodoulou, M.; Dickler, M.; Goldfarb, S.; Lake, D.; Fasano, J.; Fornier, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • The development of dose-dense adjuvant chemotherapy
    Journal Article

    Hudis, C.; Dang, C.
    Breast Journal (2015)

    Fulltext@MSK | Save
  • Adjuvant systemic chemotherapy in early breast cancer
    Book Section

    Dang, C.; Hudis, C. A.
    In Harris, J. R.; Lippman, M. E.; Morrow, M.; Osborne, C. K. (Eds.) Diseases of the Breast. 5th ed (2014)

    Fulltext@MSK | Save